Joel Greenblatt Rhythm Pharmaceuticals, Inc. Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 9,471 shares of RYTM stock, worth $554,905. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,471
Previous 12,627
24.99%
Holding current value
$554,905
Previous $518,000
4.25%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RYTM
# of Institutions
191Shares Held
67.3MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$423 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$395 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$375 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$356 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$227 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.26B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...